u/MispricedAssets

Author presents four counter-arguments to bears: 1) NA local billings are growing, 2) a $245M buyback is large relative to market cap (<$500M), 3) a 1.79% stake in SumUp could be worth ~$179M if SumUp files for IPO, 4) CEO has high incentive alignment with personal purchases at $11.30 and Performance Stock Units vesting up to $82. The market is pricing GRPN as a dying business, ignoring these positive catalysts and asset value, creating a mispricing opportunity. GRPN is fundamentally undervalued with multiple near-term catalysts for price appreciation. Core business could resume decline; SumUp IPO may not happen or may disappoint; buyback may not be executed effectively; bearish analyst reports (e.g., Goldman's $10 target) could pressure stock.